STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success

As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.

2 across the spectrum. Choose a side on the bar to jump to it.

National story. 3 articles from 2 sources. Updated 7d ago.

How each side is putting it

Left

0 sources

No Left coverage yet.

A blind spot on this side of the story.

Center

1 source
STATCenter· 7d ago

STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success

STATCenter· 7d ago

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

Right

1 source
Investor's Business DailyRight· 7d ago

Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug